Abstract
Patients with type 2 diabetes have lower quality of life, which is further impaired by diabetes complications and comorbidities. This study aims to evaluate the impact of diabetes complications and comorbidities on EuroQol Five-Dimension Three-Level (EQ-5D-3L) scores among patients with type 2 diabetes with ongoing oral drug treatments in China. This retrospective cross-sectional analysis included 9570 patients with type 2 diabetes on oral drug treatments, who were enrolled from 75 hospitals in nine cities in China. Patient characteristics, including demographic data, health conditions, oral treatment history, and health insurance coverage, were collected through self-reported questionnaires. Health utility was measured by the EQ-5D-3L scale in the questionnaire and a Chinese version of the EQ-5D-3L scoring weights was applied in the analysis. The associations between complications and health utility were assessed using linear regression. A total of 7081 patients with complete survey data were included in the analytic sample; 3479 (49.13%) patients were female. The mean age was 59.6 years old, with a standard deviation (SD) of 12.64. The average duration with type 2 diabetes was 7.91 (SD = 6.22) years. A total of 5189 (73.28%) ...Continue Reading
References
Feb 13, 2009·Current Medical Research and Opinion·Changyu PanHui Tian
Mar 11, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Milton C WeinsteinAlistair McGuire
Jun 29, 2010·Health and Quality of Life Outcomes·Zhaolan LiuBiao Xu
Apr 7, 2011·The Journal of Clinical Hypertension·Amanda N Long, Samuel Dagogo-Jack
Apr 25, 2012·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Huey-Fen Wang, Mei Chang Yeh
Jul 11, 2012·Clinical Endocrinology·K VenkataramanJ Thumboo
Jul 28, 2012·Diabetes Care·Ping ZhangWilliam H Herman
Jul 13, 2013·Health Economics·Maria AlvaPhilip Clarke
May 9, 2014·International Journal of Environmental Research and Public Health·Aliasghar A KiadaliriKatarina Steen Carlsson
Aug 21, 2014·Health and Quality of Life Outcomes·Nuria AlcubierreDidac Mauricio
Oct 25, 2014·Health and Quality of Life Outcomes·Anne NeumannLars Lindholm
Dec 3, 2014·Diabetes & Metabolic Syndrome·Sheikh Mohammed Shariful IslamAndreas Lechner
Apr 1, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Varun VaidyaJack Sheehan
Aug 1, 2015·Journal of Diabetes and Its Complications·Laura SalvotelliGiacomo Zoppini
Jan 23, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Alison HayesPhilip Clarke
Aug 30, 2016·PloS One·Yunyu HuangWen Chen
May 13, 2018·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Chao YangXiaoyuan Bao
Mar 8, 2019·BMC Public Health·Wenhui MaoWen Chen
Citations
Jun 14, 2020·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Chen-Wei PanPei Wang
Oct 18, 2020·Acta Diabetologica·Chaoyun LiPei Wang
Dec 4, 2020·BMC Medicine·Shuyan GuHengjin Dong
Dec 22, 2020·Frontiers in Public Health·Chao RongXiao-Lan Wang
Apr 27, 2021·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Hassan KaramiSomayeh Afshari
Jul 11, 2021·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Chiu Hang MokJianchao Quan
Jul 12, 2021·BMC Public Health·Xiaoxiao ChenNa Wang
Jul 22, 2021·Journal of Comparative Effectiveness Research·Xuanqian XieAndrei Volodin